11.18
price down icon0.09%   -0.03
 
loading

Finanzdaten der Celcuity Inc-Aktie (CELC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
14.01%
22.49
19.73 18.90 15.06 12.55
Interest Income/Expense
0.25%
1.4007
1.3972 1.3721 1.315 1.242
Operating Income/Loss
14.01%
-22.49
-19.73 -18.90 -15.06 -12.55
Income/Loss From Continuing Operations Before Tax
14.66%
-21.61
-18.85 -18.40 -14.59 -11.94
Income/Loss From Continuing Operations After Tax
14.66%
-21.61
-18.85 -18.40 -14.59 -11.94
Net Income/Loss
14.66%
-21.61
-18.85 -18.40 -14.59 -11.94
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,811%
33.61
1.7593 22.12 21.96 21.68
Diluted Average Shares
1,811%
33.61
1.7593 22.12 21.96 -0.1374
Basic Earnings Per Share
0.00%
-0.64
-0.64 -0.83 -0.66 -0.55
Diluted Earnings Per Share
0.00%
-0.64
-0.64 -0.83 -0.66 -0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.90
price down icon 0.86%
$38.53
price up icon 7.33%
$372.13
price up icon 1.15%
$23.81
price up icon 7.74%
biotechnology ONC
$218.57
price down icon 0.06%
$114.37
price down icon 2.46%
Kapitalisierung:     |  Volumen (24h):